Cargando…
The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy
Leishmania (L.) amazonensis is one of the etiological agents of cutaneous leishmaniasis (CL) in Brazil. Currently, there is no vaccine approved for human use against leishmaniasis, although several vaccine preparations are in experimental stages. One of them is Leishvacin, or LaAg, a first-generatio...
Autores principales: | Pratti, Juliana Elena Silveira, da Fonseca Martins, Alessandra Marcia, da Silva, Juliana Paiva, Ramos, Tadeu Diniz, Pereira, Joyce Carvalho, Firmino-Cruz, Luan, Oliveira-Maciel, Diogo, Vieira, Thiago Soares de Souza, Lacerda, Leandra Linhares, Vale, Andre Macedo, Freire-de-Lima, Celio G., Gomes, Daniel C. Oliveira, Saraiva, Elvira M., Rossi-Bergmann, Bartira, de Matos Guedes, Herbert Leonel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405171/ https://www.ncbi.nlm.nih.gov/pubmed/30802247 http://dx.doi.org/10.1371/journal.pntd.0007146 |
Ejemplares similares
-
Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice
por: Pratti, Juliana Elena Silveira, et al.
Publicado: (2016) -
MPLA and AddaVax(®) Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis
por: Oliveira-Maciel, Diogo, et al.
Publicado: (2021) -
Dietary Vitamin D3 Deficiency Increases Resistance to Leishmania (Leishmania) amazonensis Infection in Mice
por: Bezerra, Izabella Pereira da Silva, et al.
Publicado: (2019) -
Characterization of Sv129 Mice as a Susceptible Model to Leishmania amazonensis
por: dos-Santos, Júlio Souza, et al.
Publicado: (2019) -
Intranasal vaccination with extracellular serine proteases of Leishmania amazonensis confers protective immunity to BALB/c mice against infection
por: de Matos Guedes, Herbert Leonel, et al.
Publicado: (2014)